(1)
Patachi, B.; Jensen, K. H.; Gothelf, A.; Bernsdorf, M.; Friborg, J.; Kristensen, C. A. Pembrolizumab As First-Line Treatment for Recurrent and Metastatic Head and Neck Cancer – Real-World Single-Centre Data. AO 2025, 64, 143-146.